DEP domain-containing mTOR-interacting protein in the rat brain: Distribution of expression and potential implication

Journal of Comparative Neurology

Volumn 523, Issue 1, 2015, Pages 93-107

  Caron, Alexandre ^a   Baraboi, Elena Dana ^a   Laplante, Mathieu ^a   Richard, Denis ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

DEPTOR; Energy balance; Hypothalamus; In situ hybridization; MTOR; Obesity

Indexed keywords

DEP DOMAIN CONTAINING MTOR INTERACTING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROOPIOMELANOCORTIN; UNCLASSIFIED DRUG; DEPTOR PROTEIN, RAT; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN STEM; CEREBELLUM; CIRCUMVENTRICULAR ORGAN; ENERGY BALANCE; FOREBRAIN; MALE; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; ANATOMY AND HISTOLOGY; ANIMAL; BRAIN; FLUORESCENT ANTIBODY TECHNIQUE; FOOD DEPRIVATION; GENETICS; IN SITU HYBRIDIZATION; LIPID DIET; METABOLISM; OBESITY; PHYSIOLOGY; WESTERN BLOTTING; WISTAR RAT; ZUCKER RAT;

ANIMALS; BLOTTING, WESTERN; BRAIN; DIET, HIGH-FAT; FLUORESCENT ANTIBODY TECHNIQUE; FOOD DEPRIVATION; IN SITU HYBRIDIZATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; OBESITY; PRO-OPIOMELANOCORTIN; RATS, WISTAR; RATS, ZUCKER; RNA, MESSENGER;

EID: 84909607931     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23668     Document Type: Article

References (40)

1. Aggarwal D, Fernandez ML, Soliman GA. 2006. Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs. Metab Clin Exp 55:794-802.
2. Baraboi ED, Smith P, Ferguson AV, Richard D. 2010. Lesions of area postrema and subfornical organ alter exendin-4-induced brain activation without preventing the hypophagic effect of the GLP-1 receptor agonist. Am J Physiol Regul Integr Comp Physiol 298:R1098-1110.
3. Blouet C, Ono H, Schwartz GJ. 2008. Mediobasal hypothalamic p70 S6 kinase 1 modulates the control of energy homeostasis. Cell Metab 8:459-467.
4. Bolborea M, Dale N. 2013. Hypothalamic tanycytes: potential roles in the control of feeding and energy balance. Trends Neurosci 36:91-100.
5. Brundage ME, Tandon P, Eaves DW, Williams JP, Miller SJ, Hennigan RH, Jegga A, Cripe TP, Ratner N. 2014. MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. Oncogene, in press.
6. Choi YH, Fujikawa T, Lee J, Reuter A, Kim KW. 2013. Revisiting the ventral medial nucleus of the hypothalamus: the roles of SF-1 neurons in energy homeostasis. Front Neurosci 7:71.
7. Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, Woods SC, Seeley RJ. 2006. Hypothalamic mTOR signaling regulates food intake. Science 312:927-930.
8. de Bilbao F, Arsenijevic D, Vallet P, Hjelle OP, Ottersen OP, Bouras C, Raffin Y, Abou K, Langhans W, Collins S, Plamondon J, Alves-Guerra MC, Haguenauer A, Garcia I, Richard D, Ricquier D, Giannakopoulos P. 2004. Resistance to cerebral ischemic injury in UCP2 knockout mice: evidence for a role of UCP2 as a regulator of mitochondrial glutathione levels. J Neurochem 89:1283-1292.
9. Fernandez-Saiz V, Targosz BS, Lemeer S, Eichner R, Langer C, Bullinger L, Reiter C, Slotta-Huspenina J, Schroeder S, Knorn AM, Kurutz J, Peschel C, Pagano M, Kuster B, Bassermann F. 2013. SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma. Nat Cell Biol 15:72-81.
10. Fraenkel M, Ketzinel-Gilad M, Ariav Y, Pappo O, Karaca M, Castel J, Berthault MF, Magnan C, Cerasi E, Kaiser N, Leibowitz G. 2008. mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes 57:945-957.
11. Fry M, Ferguson AV. 2007. The sensory circumventricular organs: brain targets for circulating signals controlling ingestive behavior. Physiol Behav 91:413-423.
12. Hornby PJ. 2001. Central neurocircuitry associated with emesis. Am J Med 111(suppl 8A):106S-112S.
13. Houde VP, Brule S, Festuccia WT, Blanchard PG, Bellmann K, Deshaies Y, Marette A. 2010. Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes 59:1338-1348.
14. Johnson SC, Rabinovitch PS, Kaeberlein M. 2013. mTOR is a key modulator of ageing and age-related disease. Nature 493:338-345.
15. Kocalis HE, Hagan SL, George L, Turney MK, Siuta MA, Laryea GN, Morris LC, Muglia LJ, Printz RL, Stanwood GD, Niswender KD. 2014. Rictor/mTORC2 facilitates central regulation of energy and glucose homeostasis. Mol Metab 3:394-407.
16. Kohno D, Yada T. 2012. Arcuate NPY neurons sense and integrate peripheral metabolic signals to control feeding. Neuropeptides 46:315-319.
17. Laplante M, Sabatini DM. 2009. mTOR signaling at a glance. J Cell Sci 122:3589-3594.
18. Laplante M, Sabatini DM. 2012. mTOR signaling in growth control and disease. Cell 149:274-293.
19. Laplante M, Horvat S, Festuccia WT, Birsoy K, Prevorsek Z, Efeyan A, Sabatini DM. 2012. DEPTOR cell-autonomously promotes adipogenesis, and its expression is associated with obesity. Cell Metab 16:202-212.
20. Meng ZX, Wang L, Xiao Y, Lin JD. 2014. The Baf60c/Deptor pathway links skeletal muscle inflammation to glucose homeostasis in obesity. Diabetes 63:1533-1545.
21. Mimee A, Smith PM, Ferguson AV. 2013. Circumventricular organs: targets for integration of circulating fluid and energy balance signals? Physiol Behav 121:96-102.
22. Miselis RR, Hyde TM, Shapiro RE. 1984. Area postrema and adjacent solitary nucleus in water and energy balance. Fed Proc 43:2969-2971.
23. Mori H, Inoki K, Munzberg H, Opland D, Faouzi M, Villanueva EC, Ikenoue T, Kwiatkowski D, MacDougald OA, Myers MG, Jr., Guan KL. 2009. Critical role for hypothalamic mTOR activity in energy balance. Cell Metab 9:362-374.
24. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. 2006. Central nervous system control of food intake and body weight. Nature 443:289-295.
25. Mu Y, Gage FH. 2011. Adult hippocampal neurogenesis and its role in Alzheimer's disease. Mol Neurodegen 6:85.
26. Peterson TR, Laplante M, Thoreen CC, Sancak Y, Kang SA, Kuehl WM, Gray NS, Sabatini DM. 2009. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137:873-886.
27. Price CJ, Hoyda TD, Ferguson AV. 2008. The area postrema: a brain monitor and integrator of systemic autonomic state. Neuroscientist 14:182-194.
28. Ropelle ER, Pauli JR, Fernandes MF, Rocco SA, Marin RM, Morari J, Souza KK, Dias MM, Gomes-Marcondes MC, Gontijo JA, Franchini KG, Velloso LA, Saad MJ, Carvalheira JB. 2008. A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet-induced weight loss. Diabetes 57:594-605.
29. Roy C, Roy MC, Gauvreau D, Poulin AM, Tom FQ, Timofeeva E, Richard D, Cianflone K. 2011. Acute injection of ASP in the third ventricle inhibits food intake and locomotor activity in rats. Am J Physiol Endocrinol Metab 301:E232-241.
30. Sarkar S, Ravikumar B, Floto RA, Rubinsztein DC. 2009. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ 16:46-56.
31. Simmons DM, Arriza JL, Swanson LW. 1989. A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radiolabeled single-stranded RNA probes. J Histotechnol 12:169-181.
32. Smith PM, Ferguson AV. 2010. Circulating signals as critical regulators of autonomic state--central roles for the subfornical organ. Am J Physiol Regul Integr Comp Physiol 299:R405-415.
33. Spencer CM, Eckel LA, Nardos R, Houpt TA. 2012. Area postrema lesions attenuate LiCl-induced c-Fos expression correlated with conditioned taste aversion learning. Physiol Behav 105:151-160.
34. Stallone G, Infante B, Grandaliano G, Gesualdo L. 2009. Management of side effects of sirolimus therapy. Transplantation 87(suppl 8):S23-26.
35. Taylor SR, Badurek S, Dileone RJ, Nashmi R, Minichiello L, Picciotto MR. 2014. GABAergic and glutamatergic efferents of the mouse ventral tegmental area. J Comp Neurol 522:3308-3334.
36. Villanueva EC, Munzberg H, Cota D, Leshan RL, Kopp K, Ishida-Takahashi R, Jones JC, Fingar DC, Seeley RJ, Myers MG, Jr. 2009. Complex regulation of mammalian target of rapamycin complex 1 in the basomedial hypothalamus by leptin and nutritional status. Endocrinology 150:4541-4551.
37. Volkers M, Doroudgar S, Nguyen N, Konstandin MH, Quijada P, Din S, Ornelas L, Thuerauf DJ, Gude N, Friedrich K, Herzig S, Glembotski CC, Sussman MA. 2014. PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity. EMBO Mol Med 6:57-65.
38. Wittmann G, Hrabovszky E, Lechan RM. 2013. Distinct glutamatergic and GABAergic subsets of hypothalamic pro-opiomelanocortin neurons revealed by in situ hybridization in male rats and mice. J Comp Neurol 521:3287-3302.
39. Yi CX, Scherer T, Tschop MH. 2011. Cajal revisited: does the VMH make us fat? Nat Neurosci 14:806-808.
40. Zhang W, Zhang C, Fritze D, Chai B, Li J, Mulholland MW. 2013. Modulation of food intake by mTOR signalling in the dorsal motor nucleus of the vagus in male rats: focus on ghrelin and nesfatin-1. Exp Physiol 98:1696-1704.